論文・総説 - 烏山　一

分割表示  473 件中 201 - 220 件目  ／  全件表示 >>

  1. Tani K, Ozawa K, Ogura H, Takahashi T, Okano A, Watari K, Matsudaira T, Tajika K, Karasuyama H, Nagata S, et al.. Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine-supplement gene therapy. Blood. 1989.09; 74 (4): 1274-1280. ( PubMed )

  2. Tonouchi N, Miwa K, Karasuyama H, Matsui H. Deletion of 3' untranslated region of human BSF-2 mRNA causes stabilization of the mRNA and high-level expression in mouse NIH3T3 cells. Biochem Biophys Res Commun. 1989.09; 163 (2): 1056-1062. ( PubMed )

  3. Yagita H, Nakamura T, Karasuyama H, Okumura K. Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc Natl Acad Sci U S A. 1989.01; 86 (2): 645-649. ( PubMed )

  4. Karasuyama H, Tohyama N, Tada T. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J Exp Med. 1989.01; 169 (1): 13-25. ( PubMed )

  5. Melchers F, Bauer SR, Berger C, Karasuyama H, Kudo A, Rolink A, Sakaguchi N, Strasser A, Thalmann P. Precursor B lymphocytes--specific monoclonal antibodies and genes. Adv Exp Med Biol. 1989; 254 87-93. ( PubMed )

  6. Karasuyama H. [Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using high-copy cDNA expression vectors] Tanpakushitsu Kakusan Koso. 1988.11; 33 (14): 2527-2532. ( PubMed )

  7. Karasuyama H, Rolink A, Melchers F. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts. J Exp Med. 1988.04; 167 (4): 1377-1390. ( PubMed )

  8. Kohno S, Karasuyama H, Yoshida K, Kobayashi H. [A study on the causative mechanism of occlusal interference on the balancing side] Nihon Hotetsu Shika Gakkai Zasshi. 1988.04; 32 (2): 505-513. ( PubMed )

  9. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol. 1988.01; 18 (1): 97-104. ( PubMed )

  10. Asano Y, Nakayama T, Kubo M, Fujisawa I, Karasuyama H, Singer A, Hodes RJ, Tada T. Analysis of two distinct B cell activation pathways mediated by a monoclonal T helper cell. II. T helper cell secretion of interleukin 4 selectively inhibits antigen-specific B cell activation by cognate, but not noncognate, interactions with T cells. J Immunol. 1988.01; 140 (2): 419-426. ( PubMed )

  11. Palacios R, Karasuyama H, Rolink A. Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J. 1987.12; 6 (12): 3687-3693. ( PubMed )

  12. Staerz UD, Karasuyama H, Garner AM. Cytotoxic T lymphocytes against a soluble protein. Nature. 1987.10; 329 (6138): 449-451. ( PubMed, DOI )

  13. Lernhardt W, Karasuyama H, Rolink A, Melchers F. Control of the cell cycle of murine B lymphocytes: the nature of alpha- and beta-B-cell growth factors and of B-cell maturation factors. Immunol Rev. 1987.10; 99 241-262. ( PubMed )

  14. Karasuyama H, Kim M, Okumura K, Tada T. Heterogeneity of Igh-linked allotypic determinants expressed on functional T cell subsets as detected by monoclonal antibodies. Eur J Immunol. 1984.05; 14 (5): 413-420. ( PubMed )

  15. Abe R, Karasuyama H, Yagi J, Tada T. Regulation of allotype-linked NPb idiotype by an idiotype-positive soluble factor derived from a T cell hybridoma. Coupling of the circuit regulation to the network concept. Int Arch Allergy Appl Immunol. 1984; 74 (4): 289-296. ( PubMed )

  16. Tada T, Okumura K, Yamada S, Kitahara T, Karasuyama H, Ochi A, Yamauchi K. Regulation of tumor-specific immune response by T cell products. Prog Clin Biol Res. 1983; 132B 345-351. ( PubMed )

  17. Tada T, Okumura K, Miyatani S, Ochi A, Nakauchi H, Karasuyama H. Restricting elements in the immunological circuitry: the role of I region-controlled determinants. Ann N Y Acad Sci. 1983; 418 189-197. ( PubMed )

  18. 伊藤 潤哉, 三宅 健介, 烏山 一. 1細胞RNAシーケンス解析による好塩基球分化機構の解明 臨床免疫・アレルギー科. 2024.05; 81 (5): 497-503. ( 医中誌 )

  19. 三宅 健介, 伊藤 潤哉, 烏山 一. 【免疫応答の制御におけるマスト細胞,好塩基球の新たな役割】好塩基球分化とその機能に関する新知見 日本薬理学雑誌. 2024.01; 159 (1): 32-38. ( 医中誌 )

  20. Miyake K, Ito J, Karasuyama H. [Recent advances in understanding of basophil function and differentiation]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2024; 159 (1): 32-38. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲